Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications
- 1 February 1999
- journal article
- review article
- Vol. 12 (1) , 42-46
Abstract
It is generally accepted that high glucose levels for many years are a primary cause of most long-term complications in diabetic patients, Many studies suggest that the central features of diabetic complications are caused by the hyperglycaemia-accelerated formation of non-enzymatic glycated products, Non-enzymatic glycation, hovewer, has been recently demonstrated to be linked to glucose auto-oxidative process, At the same time glycated proteins have been shown to be a source of free radicals. These findings raised the hypothesis of a link between oxidative stress and the development of diabetic complications. Some studies have recently demonstrated that antioxidants, such as vitamin C and E, may reduce in vitro and in vivo protein glycation. At the same time some antioxidants act as scavengers of the free radicals produced by non-enzymatic glycation in vitro, Such studies may lead to therapeutic approaches for limiting the damage from glycation and oxidation reactions and for complementing existing therapy for treatment of the complications of diabetes. (C) 1999, Editrice Kurtis.Keywords
This publication has 24 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Meal-Generated Oxidative Stress in Type 2 Diabetic PatientsDiabetes Care, 1998
- Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetesBiochemical Journal, 1987
- Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjectsDiabetes, 1987
- Inhibitory effect of superoxide dismutase on fructosamine assay.Clinical Chemistry, 1987
- Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked FluorescenceNew England Journal of Medicine, 1986
- Heparin Preserves Antithrombin III Biological Activity from Hyperglycemia-Induced Alterations in Insulin-Dependent DiabeticsPathophysiology of Haemostasis and Thrombosis, 1986
- Decreased Antithrombin III Activity in Diabetes May Be Due to Non-Enzymatic Glycosylation – A Preliminary ReportThrombosis and Haemostasis, 1983
- Nonenzymatic Browning Products: Physiologic Effects and Metabolic Transit in Relation to Chemical Structure. A ReviewDiabetes, 1982
- Lipid peroxide level in plasma of diabetic patientsBiochemical Medicine, 1979